参考文献/References:
[1] LACKLAND D T, WEBER M A. Global burden of
cardiovascular disease and stroke: hypertension at the
core[J]. The Canadian Journal of Cardiology, 2015,
31(5): 569-571.
[2] 中国高血压基层管理指南修订委员会. 中国高血压
基层管理指南（2014 年修订版）[J]. 中华高血压杂志，
2015, 23(1): 24-43.
Revision Committee of Chinese Guidelines for the
Management of Hypertension in the Community.
Chinese guidelines for the management of hypertension
in the community (2014 revised edition) [J]. Chinese
Journal of Hypertension，2015,23(1):24-43.
[3] 中国高血压防治指南修订委员会， 高血压联盟( 中
国），中华医学会心血管病学分会中国医师协会高
血压专业委员会, 等. 中国高血压防治指南(2018 年
修订版)[J]. 中国心血管杂志, 2019,24(1):24-56.
Chinese Guidelines for the Management of
Hypertension, Chinese Hypertension League, Chinese
Society of Cardiology, Chinese Medical Doctor
Association Hypertension Committee,et al. 2018
Chinese guidelines for the management of hypertension
[J]. Chinese Journal of Cardiovascular Medicine.
2019,24(1):24-56.
[4] BURGAZ A, ORSINI N, LARSSON S C, et al. Blood
25-hydroxyvitamin D concentration and hypertension: a
meta-analysis[J]. Journal of Hypertension, 2011, 29(4):
636-645.
[5] KUNUTSOR S K, APEKEY T A, STEUR M. Vitamin
D and risk of future hypertension: meta-analysis of 283
537 participants[J]. European Journal of Epidemiology,
2013, 28(3): 205-221.
[6] GIALLAURIA F, MILANESCHI Y, TANAKA T. Arterial
stiffness and vitamin D levels: the Baltimore longitudinal
study of aging[J]. The Journal of Clinical Endocrinology
and Metabolism, 2012, 97(10): 3717-3723.
[7] KIM M K, IL KANG M, WON OH K， et al. The
association of serum vitamin D level witn presence of
metabolic syndrome and hypertension in middle-aged
Korean subjects[J]. Clin Endocrinol (Oxf)， 2010 ，
73(3):330-338
[8] MIRHOSSEINI N,VATANPARAST H,KIMBALL
SAMANTHA M. The association between serum
25(OH)D status and blood pressure in participants
of a community-based program taking vitamin D
supplements.[J]. Nutrients,2017,9(11):1244.
[9] DOGAN Y，SARLI B，BAKTIR A O，et al.
25-Hydroxy-vitamin D level May predict presence of
coronary collaterals in patients with chronic coronary
total occlusion[J]. Postepy Kardiol Interwencyjnej,
2015, 11(3): 191-196.
[10] 刘奕婷，蔡云飞，时景璞．25 羟维生素D 与高血压
关系的荟萃分析[J]．中华医学杂志，2012，92（18）：
1268-1271．
LIU Yiting, CAI Yunfei, SHI Jingpu. Meta-analysis
on the relationship between 25-hydroxyvitamin D
level and hypertension[J]. National Medical Journal of
China， 2012，92 (18):1268 -1271.
[11] LI Suhua, ZHU Jieming, WU Lin, et al. The association
between plasma homocysteine and ambulatory
blood pressure variability in patients with untreated
hypertension[J]. Clinica Chimica Acta, 2018, 477: 32-38.
[12] FERRI?RES J, ROUYER M V, LAUTSCH D, et al.
Suboptimal achievement of low-density lipoprotein
cholesterol targets in French patients with coronary
heart disease. Contemporary data from the DYSIS
II ACS/CHD study[J]. Archives of Cardiovascular
Diseases, 2017, 110(3): 167-178.
[13] 赵佳，左林，姜小建，等．动脉粥样硬化患者高同
型半胱氨酸血症与胆固醇逆向转运的关系[J]．现代
检验医学杂志，2019, 34（6）: 47-49, 53．
ZHAO Jia，ZUO Lin，JIANG Xiaojian，et al.
Relationship between hyperhomocysteinemia
and reverse cholesterol transport in patients with
atherosclerosis[J].Journal of Modern Laboratory
Medicine,2019,34(6):47-49,53.
[14] ROSENDORFF C，LACKLAND D T，ALLISON
M，et al. Treatment of hypertension in patients with
coronary artery disease: a scientific statement from
the American Heart Association, American College of
Cardiology, and American Society of Hypertension[J].
Journal of the American Society of Hypertension，
2015，9(6):453-498.
[15] PRANAVCHAND R, REDDY B M. Current status of
understanding of the genetic etiology of coronary heart
disease[J]. Journal of Postgraduate Medicine, 2013,
59(1): 30-41.
[16] 霍静，姜海军，王亚军，等．原发性高血压患者血
浆Hcy 水平与血压变异性的相关性分析[J]．山东
医药，2019, 59（2）: 49-51．
HUO Jing, JIANG Haijun, WANG Yajun，et al.
Correlation between plasma Hcy and blood pressure
variability in essential hypertensive patients[ J ].
Shandong Medical Journal. 2019,59(2):49-51.
[17] ROSENSON R S, BREWER H B, ANSELL B J, et al.
Dysfunctional HDL and atherosclerotic cardiovascular
disease[J]. Nature Reviews Cardiology, 2016, 13(1): 48-60.
相似文献/References:
[1]赵晓娟,权青云,张 愉.老年高血压患者血清胱抑素C 水平与认知障碍的相关性研究[J].现代检验医学杂志,2020,35(01):136.[doi:10.3969/j.issn.1671-7414.2020.01.036]
ZHAO Xiao-juan,QUAN Qing-yun,ZHANG Yu.Correlation between Serum Cystatin-C Level and Congnitive Impairment in Elderly Patients with Hypertension[J].Journal of Modern Laboratory Medicine,2020,35(03):136.[doi:10.3969/j.issn.1671-7414.2020.01.036]
[2]韩登科,房绮梅,谢晋烨,等.2 型糖尿病并发高血压患者血清Fetuin B 水平检测及与Hcy 浓度的相关性研究[J].现代检验医学杂志,2020,35(02):24.[doi:10.3969 ／ j.issn.1671-7414.2020.02.008]
HAN Deng-ke,FANG Qi-mei,XIE Jin-ye,et al.Serum Fetuin B Level in Patients with Type 2 Diabetes Mellitus Complicated withHypertension and Its Correlation with Hcy Concentration were Investigated[J].Journal of Modern Laboratory Medicine,2020,35(03):24.[doi:10.3969 ／ j.issn.1671-7414.2020.02.008]
[3]张亚兰,王静利,王 苗.年龄相关性白内障患者血清补体 C3，C4 及25-(OH)-D 水平检测的相关性研究[J].现代检验医学杂志,2020,35(02):49.[doi:10.3969/j.issn.1671-7414.2020.02.015]
ZHANG Ya-lan?,WANG Jing-li?,WANG Miao?.Correlational Research on Serum Levels of Complement C 3, C 4 and25-(OH)-D Levels in Patients with Age-related Cataract[J].Journal of Modern Laboratory Medicine,2020,35(03):49.[doi:10.3969/j.issn.1671-7414.2020.02.015]
[4]廖衍强.糖尿病并发高血压患者血清Cys C 与P 物质水平之间的关系研究[J].现代检验医学杂志,2020,35(02):65.[doi:10.3969/j.issn.1671-7414.2020.02.019]
LIAO Yan-qiang.Relationship between Serum Cys C and Substance P Levels in Patientswith Diabetes Mellitus Complicated with Hypertension[J].Journal of Modern Laboratory Medicine,2020,35(03):65.[doi:10.3969/j.issn.1671-7414.2020.02.019]
[5]陈伟芝,张 宁.高血压病患者血清CXCL9 和 SGK1 水平检测与心肌纤维化的相关性研究[J].现代检验医学杂志,2020,35(03):47.[doi:10.3969/j.issn.1671-7414.2020.03.011]
CHEN Wei-zhi,ZHANG Ning.Correlation between Serum CXCL9 and SGK1 Levels and Myocardial
Fibrosis in Hypertension[J].Journal of Modern Laboratory Medicine,2020,35(03):47.[doi:10.3969/j.issn.1671-7414.2020.03.011]
[6]罗星星,郑雪莲,张瑞娴,等.高血压并发动脉粥样硬化患者血清同型半胱氨酸水平与凝血功能的相关性研究[J].现代检验医学杂志,2021,36(03):144.[doi:10.3969/j.issn.1671-7414.2021.03.033]
LUO Xing-xing,ZHENG Xue-lian,ZHANG Rui-xian,et al.Correlation between Serum Homocysteine Level and Coagulation Function inPatients with Hypertension Complicated with Atherosclerosis[J].Journal of Modern Laboratory Medicine,2021,36(03):144.[doi:10.3969/j.issn.1671-7414.2021.03.033]
[7]张训男,彭春艳,李显东,等.冠心病并发高血压患者外周血白细胞SREBP-1 mRNA表达水平与脂质代谢紊乱的关系研究[J].现代检验医学杂志,2021,36(05):1.[doi:10.3969/j.issn.1671-7414.2021.05.001]
ZHANG Xun-nan,PENG Chun-yan,LI Xian-dong,et al.Correlation Analysis between Leukocytes SREBP-1 mRNA Expression andSerum Lipids Level in Hypertensive Patients with Coronary Artery Disease[J].Journal of Modern Laboratory Medicine,2021,36(03):1.[doi:10.3969/j.issn.1671-7414.2021.05.001]